Drug Profile
Research programme: cell therapies - Celixir
Alternative Names: iOMP cell therapy - Celixir; iRP cell therapy - Celixir; SkincelLatest Information Update: 28 Jul 2021
Price :
$50
*
At a glance
- Originator Celixir
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Skin disorders; Type 1 diabetes mellitus
Most Recent Events
- 28 Jul 2021 No recent reports of development identified for research development in Cancer in United Kingdom (Parenteral)
- 28 Jul 2021 No recent reports of development identified for research development in Type-1 diabetes mellitus in United Kingdom (Parenteral)
- 28 Jul 2019 No recent reports of development identified for research development in Skin-disorders in United Kingdom